AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,705,000 | -3.7% | 57,682 | +54.7% | 0.00% | -20.0% |
Q1 2019 | $1,771,000 | -22.5% | 37,282 | -41.1% | 0.01% | -28.6% |
Q4 2018 | $2,284,000 | +520.7% | 63,282 | +957.9% | 0.01% | +600.0% |
Q3 2018 | $368,000 | -17.7% | 5,982 | -9.6% | 0.00% | 0.0% |
Q2 2018 | $447,000 | +42.8% | 6,620 | +14.8% | 0.00% | 0.0% |
Q1 2018 | $313,000 | -82.5% | 5,766 | -92.1% | 0.00% | -83.3% |
Q4 2015 | $1,788,000 | +37.3% | 73,411 | 0.0% | 0.01% | +20.0% |
Q3 2015 | $1,302,000 | +0.5% | 73,411 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $1,296,000 | -43.7% | 73,411 | 0.0% | 0.01% | -37.5% |
Q1 2015 | $2,301,000 | +7.4% | 73,411 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $2,143,000 | +48.4% | 73,411 | +5.2% | 0.01% | +60.0% |
Q3 2014 | $1,444,000 | +9.4% | 69,791 | +30.9% | 0.01% | 0.0% |
Q2 2014 | $1,320,000 | +35.9% | 53,300 | +16.4% | 0.01% | +25.0% |
Q1 2014 | $971,000 | +18.0% | 45,800 | 0.0% | 0.00% | +33.3% |
Q4 2013 | $823,000 | – | 45,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |